Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Liao, Yun ^a   Hu, Xin ^a   Chen, Jie ^a   Cai, Bei ^a   Tang, Jiangtao ^a   Ying, Binwu ^a   Wang, Haiqing ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; EVIDENCE BASED MEDICINE; GENE; GENE DELETION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; P53 GENE; PRE S GENE; PROMOTER REGION; SYSTEMATIC REVIEW; AMINO ACID SUBSTITUTION; CONFIDENCE INTERVAL; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; META ANALYSIS; MUTATION; PUBLISHING; RISK; RISK FACTOR; VIRUS GENOME;

HEPATITIS B VIRUS;

AMINO ACID SUBSTITUTION; CARCINOMA, HEPATOCELLULAR; CONFIDENCE INTERVALS; GENE DELETION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MUTATION; ODDS RATIO; PUBLICATION BIAS; RISK FACTORS;

EID: 84861731096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038394     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: A Cancer Journal for Clinicians 61: 69-90.
2. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
3. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, et al. (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347: 168-174.
4. Yin J, Xie J, Liu S, Zhang H, Han L, et al. (2011) Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 106: 81-92.
5. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, et al. (2008) Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 57: 98-102.
6. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134.
7. Welschinger R, Kew MC, Viana R, Badri M, (2010) T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 22: 541-545.
8. Kim JK, Chang HY, Lee JM, Baatarkhuu O, Yoon YJ, et al. (2009) Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. J Med Virol 81: 1002-1008.
9. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, et al. (2011) Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis 203: 646-654.
10. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, et al. (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
11. Yin J, Xie J, Zhang H, Shen Q, Han L, et al. (2010) Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. Journal of Gastroenterology 45: 1063-1071.
12. Bruix J, Sherman M, (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208-1236.
13. Chan HLY, Hui A, Wong M, Tse AML, Hung LCT, et al. (2004) Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53: 1494.
14. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, et al. (2007) Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 195: 5-11.
15. Truong BX, Yano Y, Seo Y, Phuong TM, Tanaka Y, et al. (2007) Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol 79: 1293-1304.
16. Liu S, Zhang H, Gu C, Yin J, He Y, et al. (2009) Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101: 1066-1082.
17. Zheng JX, Zeng Z, Zheng YY, Yin SJ, Zhang DY, et al. (2011) Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients. J Viral Hepat 18: e423-431.
18. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG, (2007) Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int 27: 1356-1363.
19. Jang JW, Chun JY, Park YM, Shin SK, Yoo W, et al. (2012) Mutational complex genotype of the hepatitis B virus X/precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Sci 103: 296-304.
20. Zhu Y, Jin Y, Guo X, Bai X, Chen T, et al. (2010) Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 19: 2623-2630.
21. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, et al. (2008) Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 198: 1634-1642.
22. Lee MH, Kim DY, Kim JK, Chang HY, Kang SH, et al. (2011) Combination of preS Deletions and A1762T/G1764A Mutations in HBV Subgenotype C2 Increases the Risk of Developing HCC. Intervirology.
23. Utama A, Siburian MD, Fanany I, Intan MD, Dhenni R, et al. (2011) Low prevalence of hepatitis B virus pre-s deletion mutation in Indonesia. J Med Virol 83: 1717-1726.
24. Lok ASF, McMahon BJ, (2007) Chronic hepatitis B. Hepatology 45: 507-539.
25. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
26. Jang J, Lee Y, Kim M, Lee S, Bae S, et al. (2007) A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis. Journal of viral hepatitis 14: 169-175.
27. Kusakabe A, Tanaka Y, Inoue M, Kurbanov F, Tatematsu K, et al. (2011) A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. J Gastroenterol 46: 117-124.
28. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, et al. (2008) Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100: 1134-1143.
29. Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, Alavian SM, Behzad-Behbahani A, et al. (2008) Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol 14: 5448-5453.
30. Huy TT, Ushijima H, Quang VX, Ngoc TT, Hayashi S, et al. (2004) Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam. J Med Virol 74: 228-236.
31. Bai J, (2007) Investigation on mutations of hepatitis B virus gene in the patients with hepatocellular carcinoma [Chinese]. Chinese Journal of Infectious Diseases 10: 617-620.
32. Yan T, Li K, Li F, Su H, Mu J, et al. (2011) T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C. Journal of Medical Virology 83: 996-1004.
33. Elkady A, Tanaka Y, Kurbanov F, Oynsuren T, Mizokami M, (2008) Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia. J Gastroenterol Hepatol 23: 474-481.
34. Chen CH, Changchien CS, Lee CM, Tung WC, Hung CH, et al. (2009) A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan. International Journal of Cancer 125: 621-629.
35. Guo X, Jin Y, Qian GS, Xu L, Tu H, (2007) Full-genome sequence analysis of hepatitis B virus isolated from hepatocellular carcinoma in high incidence area Qidong. Tumor 27: 429-432.
36. Ito K, Tanaka Y, Kato M, Fujiwara K, Sugauchi F, et al. (2007) Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion. J Gastroenterol 42: 837-844.
37. Song BC, Kim H, Kim SH, Cha CY, Kook YH, et al. (2005) Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol 75: 13-19.
38. Liu S, Xie J, Yin J, Zhang H, Zhang Q, et al. (2011) A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma. J Med Virol 83: 45-53.
39. Lyu H, Chung YH, Kim JA, Lee D, Lee JH, et al. (2011) Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype C2 hepatitis B virus genome on the occurrence of hepatocellular carcinoma. J Hepatol 54: S151-S152.
40. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, et al. (2006) Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 45: 646-653.
41. Laskus T, Radkowski M, Nowicki M, Wang LF, Vargas H, et al. (1998) Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. Biochem Biophys Res Commun 244: 812-814.
42. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, et al. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588-591.
43. Brunetto MR, Stemler M, Bonino F, Schodel F, Oliveri F, et al. (1990) A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 10: 258-261.
44. Kwon H, Lok AS, (2011) Hepatitis B therapy. Nat Rev Gastroenterol Hepatol 8: 275-284.
45. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, et al. (2007) Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14: 161-168.
46. Chan HLY, Wong GLH, Tse CH, Chim AML, Yiu KKL, et al. (2009) Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol H 7: 1361-1366.
47. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, et al. (2005) Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97: 265-272.